SCHEMBL20061893

SCHEMBL20061893

CCCC1(CCC)c2cc(C(=O)/C(Cc3cccc(C)c3)=N/OC(C)=O)ccc2-c2ccc(C(=O)c3ccccc3C)cc21

nearest known ligand 0.34

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CTBP2 P56545 1/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ POLB P06746 1/20 0.31
▸ TDP1 Q9NUW8 2/20 0.31
▸ SRD5A2 P31213 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23895113 0.91 NPC1 (0.38) CTBP2L3MBTL1KMT2ARAB9A
SCHEMBL20061894 0.85 CTBP2 (0.35) CTBP2L3MBTL1MAOBACHE
SCHEMBL18122992 0.84 ALDH1A1 (0.34) POLBALDH1A1HTTKMT2ARAB9A
SCHEMBL20090053 0.84 PDK2 (0.34) CTBP2L3MBTL1TDP1
SCHEMBL20061892 0.83 SMN1; SMN2 (0.41) CTBP2L3MBTL1TDP1MAOBALDH1A1
SCHEMBL17877627 0.83 ALDH1A1 (0.36) L3MBTL1POLBALDH1A1HTTKMT2A
SCHEMBL17056227 0.83 ALDH1A1 (0.36) L3MBTL1POLBALDH1A1HTTKMT2A
SCHEMBL17084350 0.83 ALDH1A1 (0.36) L3MBTL1POLBALDH1A1HTTKMT2A
SCHEMBL29789550 0.83 ALDH1A1 (0.36) L3MBTL1POLBALDH1A1HTTKMT2A
SCHEMBL18122994 0.82 FFAR1 (0.33) POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542397-B2 Liquid composition, quantum dot-containing film, optical film, light-emitting display element panel, and light-emitting display device TOKYO OHKA KOGYO CO., LTD. (JP) 2023-01-03 — — US disclosed
US-20210309866-A1 LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LIGHT-EMITTING DISPLAY ELEMENT PANEL, AND LIGHT-EMITTING DISPLAY DEVICE TOKYO OHKA KOGYO CO., LTD. (JP) 2021-10-07 — — US disclosed
US-20190332012-A9 PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM UBE CORPORATION (JP) 2019-10-31 — — US disclosed
US-20180107114-A1 PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM TOKYO OHKA KOGYO CO LTD (JP) 2018-04-19 — — US disclosed
US-20180107114-A1 PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM TOKYO OHKA KOGYO CO LTD (JP) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180107114-A1 PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM RARA, LCP1, CUTA CTBP2 1252/4885L3MBTL1 4071/4885POLB 3523/4885
US-20190332012-A9 PHOTOSENSITIVE RESIN COMPOSITION, POLYAMIDE RESIN, METHOD FOR PRODUCING POLYAMIDE RESIN, COMPOUND, METHOD FOR PRODUCING COMPOUND, METHOD FOR PRODUCING CURED FILM, AND CURED FILM RARA, LCP1, CUTA CTBP2 1252/4885L3MBTL1 4071/4885POLB 3523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback